Role of interleukin-12 (IL 12) as an anti-tumour agent: experimental biology and clinical application

This publication has 16 references indexed in Scilit:

• Mouse interleukin‐12 (IL‐12) p40 homodimer: a potent IL‐12 antagonist
  European Journal of Immunology, 1995
• CD4 T cells inhibitin vivo the CD8-mediated immune response against murine colon carcinoma cells transduced with interleukin-12 genes
  European Journal of Immunology, 1995
• Interleukin‐12 regulates the proliferation of Th1, but not Th2 or Th0, clones
  European Journal of Immunology, 1994
• B7 and interleukin 12 cooperate for proliferation and interferon gamma production by mouse T helper clones that are unresponsive to B7 costimulation.
  The Journal of Experimental Medicine, 1994
• Interleukin 12 synergizes with B7/CD28 interaction in inducing efficient proliferation and cytokine production of human T cells.
  The Journal of Experimental Medicine, 1994
• Antitumor and antimetastatic activity of interleukin 12 against murine tumors.
  The Journal of Experimental Medicine, 1993
• Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells.
  The Journal of Experimental Medicine, 1993
• Transplantation and Adoptive Cellular Therapy of Cancer: The Role of T-Cell Growth Factors
  Cell Transplantation, 1993
• Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers.
  The Journal of Experimental Medicine, 1991
• Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes.
  The Journal of Experimental Medicine, 1989